Sunday, November 18, 2012

BMSN - Bio-Matrix Scientific Group Inc.

BMSN ~ Bio-Matrix Scientific Group Inc.

Penny Stock Traders Love Sub Pennies Because Of the Huge Gains They Can Produce
and We Think This Trading Idea Could Be a Great Opportunity For Our Members To
Possibly Capture Some Huge Gains Before Thanksgiving!

We Are Just the Start Of a Larger Campaign On This One,
So There is No Telling the Potential On This.
More The Reason To Take Notice!

Company Website ~

Company Overview

Bio-Matrix Scientific Group Inc. is a biotechnology research and development company headquartered in San Diego, Ca. with a 15,000 sq. ft. facility that houses two secure cryogenic stem cell banks, three research laboratories, aseptic cellular/tissue class 10,000/100 processing lab, hematology, microbiology and flow cytometry laboratories.

Bio-Matrix Scientific Group, Inc., a development stage company, through its subsidiary, Entest BioMedical, Inc. (ENTB), focuses on developing and commercializing therapies, medical devices, and medical testing procedures for the veterinary market, as well as on acquiring and operating veterinary clinics.

ENTB’s business model involves acquiring veterinary clinics/hospitals to be utilized as distribution channels for its immuno-therapeutic cancer vaccine for canines (dogs) that is in development stage. Bio-Matrix Scientific Group, Inc. was founded in 2005 and is based in La Mesa, California. Bio-Matrix Scientific Group, Inc. was formerly a subsidiary of BMXP Holdings, Inc.

Bio-Matrix is pursuing relationships with hospitals, medical institutes, research firms, and biotechnology companies to assist in stem cell research, cell culturing, and Regenerative Medicine therapies. Bio-Matrix's facilities are available for processing, culturing, and storage of specimens. Also, under certain situations the Company has laboratories available to organizations conducting research.

BMSN Subsidiary ~ Entest Biomedical, Inc. ~ $ENTB

Company Website ~

Entest BioMedical, Inc. develops immuno-therapeutic treatments that address illnesses and maladies in both veterinary and human medicine. Of specific interest to us are immunological vaccines for oncology (cancer vaccines) and veterinary clinic acquisitions.

The basis for the majority of our approaches is underpinned by leveraging the body's own reparative / immunological mechanisms - as opposed to using toxic chemicals.

Areas of Focus:

Currently, Entest is focused on significant therapeutic therapies that show promise for the development of under-served market niches with potential high demand.

Immuno-Therapeutic Cancer Vaccine for Canines (Dog Cancer Vaccine):

The first area of focus involves the development of an immuno-therapeutic cancer vaccine for canines. One in every four dogs will develop some sort of cancer during its lifetime.

The Company's goal in this area is to create a treatment that will jumpstart the dog's own immune system to fight cancer, and we have a device that is in development that we believe will be a "game-changer" for canine oncology.

With the rollout of our "canines first" approach, Entest feels it can penetrate the veterinary market in the very near term (one to three years) and eventually take this immuno-therapeutic cancer vaccine into human trials once enough paid animal cases support our vaccine's efficacy.

Entest Technologies: ImenVax (TM)

Immuno-Therapeutic Cancer Treatment for Canines:

In the encapsulated ImenVax™ device, a “cocktail” of integral immuno-catalysts are enclosed. From this ImenVax™ device immuno-catalysts are released which activate the patient’s immune cell. These immune cells carry on their normal course of activity by entering the lymph nodes and cause T-Cell adaptation. These T-Cells are what attack and kill the tumor.

BMSN ~ Services

Bio-Matrix’ Research Laboratories and Cryo preservation Facilities:

Microbiology Laboratory features:

Eppendorf Centrifuge
FACS Flow Cytometer
Computype GMP’ Labeling System
Cell Dyn 1800 Hematology Analyzer

Cellular Culture Laboratory features:

Jauan Floor Centrifuge
Computype GMP’ Labeling System
Forma Scientific Laminar Flow Hood
AXP Cell Separation System – Automated cell separation Closed system for Cord Blood and Peripheral Blood processing

Blood Processing Laboratory features:

Jauan Floor Centrifuge
Computype GMP’ Labeling System
Forma Scientific Laminar Flow Hood
AXP Cell Separation System – Automated cell separation Closed system for Cord Blood and Peripheral Blood processing

Adipose Processing Laboratory features:

Thermo Fisher Scientific Laminar Flow Hood
Class 10,000 20 x 20 Modular Laboratory
Computype GMP’ Labeling System
Jauan Centrifuge

Main Laboratory features:

Forma Scientific Laminar Flow Hood
Computype GMP’ Labeling System
Isotemp Laboratory Refrigerator
Jauan -80 Freezer
Allegra Centrifuge
Fraction Collector
Baxter Incubator
Isotemp Bath

Cryogenic Laboratories (2) features:

Alpha Omega Series 1000 Oxygen Monitors (in each Cryo Lab)
2 Class 100,000 Research Laboratories (completed).
Thermo Scientific 7400 CryoPlus 1 Freezer
CBS 2100 Controlled Rate Freezer
Computype GMP’ Labeling System
Thermo Scientific 744 Cryofreezer
Taylor Wharton 10K Cryofreezer
MVE Vapor Dry Shipper (2 ea)
CBS V-5000 Cryofreezer

Specially Designed, Patent Pending Instruments for Harvesting Stem Cells:

The nucleus of Bio-Matrix’s products for development and manufacture are instruments that are specifically designed to provide direct assistance in plastic / cosmetic surgery procedures, as well as for tissue management and stem cell research. To date, the Company has developed approximately 192 diagnostic instruments for these purposes. These lightweight disposable instruments offer the Surgeon the same reliability that they are accustomed to as well as the assurance of no cross-contamination or transfer of disease and will be sold individually or in surgery specific sets. The company will also include the single use device in its Adipose (Fat) Collection Kit for stem cell harvesting.

Bio-Matrix Scientific Group, Inc. is a fully reporting SEC company, publicly traded on the OTC Market under the symbol, “BMSN”, and within the OTC-QB market tier. As such, Business, Operational, and Financial information on BMSN is fully transparent and available to public view.

Visit: to see complete details.

A/S: 2 Billion Common Shares ~ per Form 14C ~ November 7, 2012
O/S: 403 million ~ per 8-K ~ November 13, 2012

(Please note the share structure posted is what we have gathered but can change on a daily basis. Contact the Company or Transfer Agent to get the most current information.)

Their latest 10-Q Quarterly Report:
Filed on 8/14/12 ~ For the period ending 6/30/12

Incorporated In: Delaware in 2005

Transfer Agent

Securities Transfer Corporation
2591 Dallas Parkway Suite 102
Frisco, Texas 75034

Fax: 469-633-0088
Phone: 469-633-0101

Marketwire ~ (October 29)
Bio-Matrix Scientific Group, Inc. Announces Participation in the 2012 Stem Cell Meeting on the Mesa's Investor and Partnering Forum

Marketwire ~ (June 26)
Bio-Matrix Scientific Group, Inc. Recruits Senior Scientist for Its Regen BioPharma Subsidiary

Marketwire ~ (June 7)
Bio-Matrix Scientific Group's Regen BioPharma Subsidiary Executes Option Agreement to License Stem Cell Intellectual Property

Marketwire ~ (April 30)
Bio-Matrix Scientific Group, Inc. Announces Newly Formed Stem Cell Subsidiary -- Regen BioPharma Inc., Secures $20,000,000 in Institutional Funding

Contact Us

Bio-Matrix Scientific Group, Inc.
4700 Spring Street, Suite 304
La Mesa, CA 9194

Phone: 619-702-1404

Previous Winning Sizzlers!

$CNOZ 880%, $ILVC 777%, $FIND 657%, $TWWI 498%, NXOI 400%

This alert brought to you by

Sign up for Our Free Newsletter

Get Free Text Alerts to Your Phone!
Text Sizzlers to 99000

Follow Us on Twitter!/SizzlinStockPix

Follow Us on Facebook

Follow Sizzling Stock Picks Blog

Follow us at PennyStockTweets

Disclaimer below

Contact Us

Penny Stocks are very volatile and with investing in any security there is always risk.

Always Educate yourself and do your own Due Diligence before investing in ANY Security.

Sources: - - -

(these are only sources and not always up to date)

If you are new to trading penny stocks we strongly advise you to spend some time trading virtual money. They say that “You never really become a real trader until you wipeout your portfolio.” We say take that wipeout while not losing your real money.

Here are a few sites where you can easily set up a virtual account:

First check your broker, some have them already like TD Ameritrade/Think or Swim

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.